PubMed HealthSearch

Biomedical subjects

A G Chuchalin

Publications and source records attributed to A G Chuchalin.

At least 19 recordsLinked to original sources

[The role of computed spirometry in the epidemiological study of respiratory symptoms].

An epidemiological study was made of a random representative sample of men and women aged 25-64 years. There were 167 men and 306 women. In order to compare forced expiration in persons with different combinations of respiratory symptoms, potentialities of the use of the forced midexpiratory flow 25-75% together with the FEVC, FEV1, FEV1/FEVC were examined. Among the flow parameters, the forced midexpiratory flow has the least variability, which permits using it for diagnosis of obstructive disorders of lung ventilatory function. The studies revealed qualitative peculiarities in the changes of the spirography readings among men and women. As compared to the examinees without respiratory symptoms, men with cough and sputum manifested a decrease in the parameters characteristic of mixed changes in lung ventilatory function with the predominance of obstructive alterations in chronic bronchitis. The degree of obstructive disorders was higher than in women showing the analogous symptoms. As compared to the examinees without respiratory symptoms, women suffering from chronic bronchitis were marked by lower values of the volumetric parameters, without any signs of forced expiration deceleration.

Diagnosis, Computer-Assisted

Serum levels of interleukin 4, interleukin 6 and interferon-gamma following in vivo isotype-specific activation of IgE synthesis in humans.

It is now generally accepted that interleukin 4 (IL4), interleukin 6 (IL6) and interferon-gamma (IFN gamma) play main roles in the regulation of human IgE synthesis. This concept is based mainly on in vitro data. To obtain corresponding in vivo data, we determined IL4, IL6 and IFN gamma by immunoassays in sera collected from 4 atopic patients following a clinical trial of selective IgE apheresis (plasmaimmunoadsorption). This treatment removes several milligrams of IgE from patient's blood and is suggested to induce strong and isotype-specific activation of the IgE system. Serum IgE levels restored rapidly within 3-5 days after IgE apheresis. However, very low and constant levels of IL4 (from less than 50 to 130 pg/ml) and IL6 (from less than 300 to 920 pg/ml) were detected in the sera of the treated patients. Serum IFN gamma was absent before treatment (concentrations less than 0.5 U/ml) and increased to low but detectable levels (0.90 and 8.05 U/ml) on the day following the last IgE apheresis in 2 of 4 patients. In our opinion, the data presented argue against in vivo participation of IL4 and IL6 in the activation of the human IgE system, at least in atopic patients under constant allergen exposure.

Adult

[An intranasal method of administration of calcitrin to steroid-dependent patients with bronchial asthma].

The efficacy of endonasal calcitrin was studied against that of intramuscular. The drug was given endonasally in a dose of 3 units twice a day during 1--1.5 months. The effect on the calcium-regulating system (total calcium, calcitonin, parathyroid hormone), external respiration, its analgetic action were similar to such of the intramuscular mode. Endonasal calcitrin is recommended for outpatient use.

Administration, Intranasal

Measurement of complement components and alpha 1-antitrypsin during plasma exchange.

Therapeutical plasma exchange can be carried out by using blood cell separators based upon centrifugation or in equipments with membranes. We investigated whether activation of the complement system took place in polyvinylchloride tubes used in the blood cell separator. We also examined the changes in the classical and alternative complement pathways by an analysis of functional haemolytic titers, as well as the levels of C4, C3D, C4, albumin and alpha 1-antitrypsin. No measurable activation of the complement system was found. The decreased levels of the C3, C3d, C4, albumin and alpha 1-antitrypsin in the sera after PE could be a consequence of the haemodilution.

Blood Group Incompatibility

Leukocytosis induced by plasma exchange.

A significant increase was found in the number of white blood cells, including neutrophils, in the peripheral blood of patients during plasma exchange. However, the spontaneous chemiluminescence of peripheral white blood cells (basically characterized the activated state of neutrophils) was not elevated. This finding suggests a relative deficiency in the metabolism of neutrophils during plasma exchange. This idea is supported by the observation that the levels of malonyldialdehyde in plasmas, after plasma exchange, do not increase, indicating that the activation dependent lipid peroxidation in neutrophils did not take place.

Humans

[Primary pulmonary hypertension].

Primary pulmonary hypertension is a progressive disease of an unknown etiology which attacks mainly young people. Metabolic disturbances of biologically active substances produced in the endotheliocytes of pulmonary vessels play the leading role in pathogenesis of the disease. They result in structural changes of the vessels wall. In spite of the variety of the morphologic changes the clinical picture of the disease is generally common. A great variety of invasive and noninvasive investigations is necessary for verification of the diagnosis. Chemotherapy fails to stop the disease progress, though the main parameters of central hemodynamics are improved under the influence of vasodilators. Foreign investigators believe heart-lung transplantation to be radical treatment of patients suffering from primary pulmonary hypertension.

Humans

[The transport of monovalent ions and calcium in the erythrocytes of patients with bronchial asthma].

The intracellular levels of sodium, potassium, and free calcium, as well as red blood cell transport of 86Rb (a radioactive potassium analogue) and 45Ca were measured in patients with bronchial asthma (BA). The intracellular content of sodium was 10-20% higher in patients with BA, though the differences in the present sample (7 controls and 18 BA patients) failed to be significant (p less than 0.05). The differences were most pronounced in infection-dependent BA and not eliminated during glucocorticoid hormone therapy. The activity of the Na+, K+ pump, as assessed by the values of an ouabain-inhibited component of 86Rb entry, was increased by 10-20% (p less than 0.05) in BA patients and of Na+, K+ cotransport (an ouabain-sensitive furosemide-inhibited component of 86Rb entry), by 35-45% (p less than 0.25). The passive red blood cell membrane permeability in BA patients (an ouabain + furosemide-insensitive component of 86Rb) remained unchanged. The quin-2-loaded red blood cell entry rate for 45Ca was decreased by 5-10%. In the absence of a Ca(2+)-ATPase inhibitor (0.5 mM orthovanadate), these differences were greatly significant (p less than 0.005). In addition, the patients with BA showed a 10% reduction in free calcium levels; however, the differences were insignificant (p less than 0.25), which might be caused by Ca-pump activation. As in the experiments with Na+ level measurements, the greatest differences in red blood cell Ca(2+)-balance control were recorded in patients with infection-dependent BA and independent of glucocorticoid hormone therapy. Possible mechanisms of involvement of the changes found in monovalent cation and Ca2+ transport in the pathogenesis of BA were also discussed.

Adult

[Use of plateletpheresis in the treatment of bronchial asthma].

It was shown that platelets of asthmatic patients notwithstanding the disease form are more sensitive to the stimulating action of platelet-activating factor (PAF) in aggregation response and intracellular Ca2+ influx induction than platelets of healthy donors. Intracellular Ca2+ influx was measured using the fluorescent probe Fura-2. Platelet apheresis was applied attempting to normalize the "hyperactivated" state of asthmatic patients' platelets. Platelet apheresis was performed using the on-line cell separator Fenwal CS-3000 in 27 patients without any considerable side effects. The mean platelet yield was 400-600 X 10(9) cells; the blood platelet count restored immediately after the treatment. Positive clinical effect (complete reduction of asthmatic attacks for at least 2 months, improvement in respiratory function parameters) was observed in 19 out of the 27 patients (70%). The clinical effect correlated well with the normalization of in-vitro platelet response to PAF.

Adult

[The clinical use of immunosorption: problems and perspectives].

The data concerning clinical use of extracorporeal immunoadsorption are summarized. At present, broad use of this therapeutic approach is hampered by several technological and medical problems such as incomplete biocompatibility of carrier, pyrogenic reactions, ligand "leakage" and rebound phenomena. However, the technology of ex vivo removal is much more developed, than the fundamental knowledge of relevant target substance to be removed in specific clinical situation. The appropriate denomination of such "targets" should provide this method with a wide application field in clinical medicine.

Blood Component Removal

[The thrombocyte function of bronchial asthma patients].

The functional characteristics of platelets were estimated in patients with different asthma forms (atopic, aspirin-sensitive and mixed ones). It was shown that platelets of asthmatics with the atopic and aspirin-sensitive disease forms are more sensitive to the stimulating action of platelet activating factor (PAF) in aggregation response and intracellular Ca2+ influx induction than platelets of patients suffering mostly from the recurrent bronchopulmonary infections with atopic component (so-called "mixed" asthma) and more activated than platelets of healthy donors. Intracellular Ca2+ influx was measured using the fluorescent probe Fura-2 in platelet suspension. Platelet aggregation was measured on aggregometer by two methods (Born's method and correlational photometric method) in platelet-rich plasma. PAF was used as inductor of platelet aggregation and fluorescence response. The antiallergic drugs ketotifen and sodium cromoglycate (intal) caused a 30-40% inhibition of PAF-induced aggregation of asthmatics' and healthy donors' platelets. It may be concluded that platelets of atopic and aspirin asthmatics are more active, their "hyper-reaction" to PAF is expressed by higher aggregability and the lower PAF concentration threshold.

Asthma